AQA
EW icon

Alpha Quant Advisors’s Edwards Lifesciences EW Stock Holding History

Alpha Quant Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$254K Sell
3,978
-783
-16% -$44.7K 0.25% 103
2018
Q4 		$243K Buy
+4,761
New +$241K 0.25% 108

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Alpha Quant Advisors's EW Position: Q1 2019 in Review

Alpha Quant Advisors reduced its Edwards Lifesciences (EW) stake by 16% in Q1 2019, selling an estimated $44.7K and leaving 3,978 shares worth $254K. The position accounts for 0.25% of the portfolio, ranked #103.

Alpha Quant Advisors first reported a position in EW in Q4 2018 and has held it in 2 quarters since. 922 funds tracked by Wall St. Rank hold EW as of Q1 2019.

  • Alpha Quant Advisors held 3,978 shares of Edwards Lifesciences worth $254K as of Q1 2019.
  • Alpha Quant Advisors sold 783 Edwards Lifesciences shares in Q1 2019, an estimated $44.7K.
  • Edwards Lifesciences made up 0.25% of Alpha Quant Advisors's portfolio in Q1 2019, its #103 holding.
  • Alpha Quant Advisors first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 2 quarters since.
  • 922 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.